tirzepatide approved for osa Medscape | The FDA Zepbound in December 2024 the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after Tirzepatide shows dual benefits in

Orforglipron vs Semaglutide: Oral GLP-1 Small Molecule vs Proven Peptide Evidence-based comparison of orforglipron and semaglutide for weight loss and type 2 diabetes, including ATTAIN, ACHIEVE-3, and STEP trial data

6 As more positive health data emerges from trials of weight loss products, the pressure increases on payers and employers to cover these products

J Japanese Soc Parenter Enter Nutr

Growth of Candida albicans hyphae

Alongside nausea, vomiting and constipation, clinicians are now seeing a marked increase in haemorrhoids (piles) among patients using GLP-1 medications a condition that can be painful, distressing and, in some cases, mistaken for more serious disease